Form 8-K - Current report:
SEC Accession No. 0000950170-25-071485
Filing Date
2025-05-14
Accepted
2025-05-14 16:30:10
Documents
11
Period of Report
2025-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mreo-20250513.htm   iXBRL 8-K 138969
  Complete submission text file 0000950170-25-071485.txt   307818

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mreo-20250513.xsd EX-101.SCH 58315
14 EXTRACTED XBRL INSTANCE DOCUMENT mreo-20250513_htm.xml XML 6519
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 25946221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)